HYPOGLYCEM
IC DRUGS
Dr Mohit Bansal
Classification
SULFONYLUREAS
BIGUANIDES
ALPHA-GLUCOSIDASE INHIBITORS
THIOZOLIDINEDIONES
MEGLITINIDES
INCRETINS
DPP- IV INHIBITORS (GLIPTINS)
OTHERS
INSULIN SECRETAGOGUES
1) SULFONYLUREAS
2) NON- SULPHONYLUREAS
a) MEGLITINIDES
b) GLP- 1 AGONISTS
c) DPP- IV INHIBITORS
SULFONYLUREAS
MOA :1. STIMULATE BETA CELLS TO
RELEASE INSULIN
(BY BINDING AND BLOCKING ATP SENSITIVE
K+ CHANNELS)
LASSIFICATION
FIRST GENERATION
TOLBUTAMIDE
CHLORPROPAMIDE
(NOT USED NOW BECAUSE OF HYPOGLYCEMIA)
SECOND GENERATION
GLICLAZIDE
GLIPIZIDE (5 MG ; 15 MG)
GLIBENCLAMIDE (GLUBURIDE)
(2.5/ 5 MG)
GLIMEPERIDE (1/ 2 MG)
IDE EFFECTS
HYPOGLYCEMIA (MORE COMMON
WITH FIRST GENERATION)
CHOLESTASIS
DILUTIONAL HYPONATREMIA
WEIGHT GAIN
HYPERINSULINEMIA
AGRANULOCYTOSIS
APLASTIC AND HEMOLYTIC
ANAEMIA
PRIMARY AND SECONDARY FAILURE (USUALLY
SEEN IN WESTERN POPULATION)
BIGUANIDES
MOA :1) INCREASE PERIPHERAL UPTAKE OF
GLUCOSE
2) IMPAIRS GLUCOSE ABSORPTION FROM GUT
3) INHIBITS GLUCONEOGENESIS IN LIVER
) GIVEN AFTER FOOD INTAKE
) C/I IN HEPATIC AND RENAL FAILURE
PATIENTS; ALCOHOLICS; PATIENTS WITH
ACTIVE INFECTIONS; PATIENTS ON ASPIRIN
LASSIFICATION
METFORMIN
500/800 MG * BD/TDS
500/1000 MG SR * OD/BD
PHENFORMIN
WITHDRAWN IN 1970s DUE TO
LACTIC ACIDOSIS
SIDE EFFECTS
LACTIC ACIDOSIS (MAIN BUT RARE)
NAUSEA, VOMITING, ANOREXIA
METALLIC TASTE
ALPHA-GLUCOSIDASE
INHIBITORS
MOA :INHIBITS DISACCHARIDASES IN THE GUT
AND DELAY CARBOHYDRATE ABSORPTION
DRUGS
ACARBOSE : 50 MG * TDS (WITH EACH
MEAL)
VOGLIBOSE : 0.2-0.3 MG * TDS
MAGLITOL : 50 MG (JUST BEFORE MEALS)
SIDE EFFECTS
FLATULENCE
DIARRHOEA
ABDOMINAL BLOATING
CONTRA- INDICATIONS
GASTROPARESIS
INFLAMMATORY BOWEL SYNDROME
CREATININE > 2 MG/ DL
THIOZOLIDINEDIONES
MOA :INCREASES INSULIN SENSITIVITY ON
PERIPHERAL TISSUES ESPECIALLY FAT
* INCREASES LDL AND HDL
* DECREASES TGs
DRUGS
PIOGLITAZONE : 15/30 MG * OD
ROSIGLITAZONE BANNED DUE TO
CARDIOVASCULAR ADVERSE EFFECTS
MEGLITINIDES
MOA :SAME AS SULFONYLUREAS
DRUGS
REPAGLINIDE : 0.5- 1 MG * TDS
NATEGLINIDE
GIVEN MULTIPLE TIMES BECAUSE OF
SHORT HALF LIFE AND SHOULD BE TAKEN
WITH MEALS
SIMILAR SIDE-EFFECTS AS THAT OF SU
BUT HYPOGLYCEMIA IS RARE
REGULATE POST PRANDIAL SUGARS WELL
INCRETINS
(GLP-1)
NEW CLASS OF DRUGS
ORAL GLUCOSE CAUSES RELEASE
OF GUT HORMONES, MAINLY
GLUCAGON LIKE PEPTIDE-1 AND
GLUCOSE INSULINOTROPHIC
POLYPEPTIDE-1, THAT AMPLIFY
THE GLUCOSE INDUCED INSULIN
RELEASE
GLP-1 SUPRESSES GLUCAGON
SECRETION
ALSO, IMPROVES PANCREATIC
DPP- IV INHIBITORS
(GLIPTINS)
DIPEPTIDYL PEPTIDASE IV INHIBITORS
POTENTIATE ACTION OF INCRETINS AS GLP-1
IS RAPIDLY PROTEOLYSED BY DPP- IV
PROMOTES INSULIN RELEASE IN PRESENCE OF
GLUCOSE AND INHIBITS WEIGHT GAIN AND
HYPERGLYCEMIA
INHIBITS RISE IN POST-PRANDIAL BLOOD
SUGAR
DRUGS
SITAGLIPTIN : 100 MG * ORAL * OD
VILDAGLIPTIN
SEXAGLIPTIN
GIVEN IN COMBINATION WITH METFORMIN
PRAMLINITIDE
SYNTHETIC ANALOGUE OF ISLET
AMYLOID POLYPEPTIDE (IAPP) OR
AMYLIN
DELAYS GASTRIC EMPTYING AND
DECREASES APETITE
SUPRESSES GLUCAGON
SECRETION
USED IN BOTH T-1 AND T-2 DM
S/C * 15 MCG WITH EACH MEAL
DAPAGLIFLOZIN
SGLT-2 INHIBITORS (INHIBITS GLUCOSE
REABSORPTION IN PROXIMAL
CONVULATED TUBULES OF KIDNEY)
SO, PROMOTES GLYCOSURIA
SIDE-EFFECTS
ELECTROLYTE IMBALANCE
GENITAL INFECTIONS
INCREASE IN FREQUENCY OF
MICTURITION
ALPHA-GLUCOSIDASE
INHIBITORS
DELAYS GLUCOSE
ABSORPTION
SULFONYLUREAS
MEGLITINIDES
AMINO ACID
DERIVATIVES
(GLP-1 AGONISTS)
INCREASE INSULIN
SECRETION
METFORMIN
INCREASE PERIPHERAL
GLUCOSE UPTAKE
THIAZOLIDINEDIONES
INCREASE INSULIN
SENSITIVITY
COMBINATIONS
SINGLE OHA : METFORMIN
COMBINATIONS :
SU + METFORMIN
SU+ PIOGLITAZONE
SU + METFORMIN +
PIOGLITAZONE
INSULIN CAN BE ADDED TO ANY
OF THE ABOVE COMBINATIONS
QUERIES/ QUESTIONS
PREFERRED DRUG TO START
TREATMENT?
HOW TO MONITOR EFFECT ?
HOW FREQUENT TO INVESTIGATE
FOR SUGAR LEVELS?
DOSES AND DRUG FREQUENCY?